Xencor Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Xencor, Inc. | ||
| Date: February 28, 2024 | By: | /s/ BASSIL I. DAHIYAT, PH.D. |
|---|---|---|
| Bassil I. Dahiyat, Ph.D.President & Chief Executive Officer | ||
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Bassil I. Dahiyat, Ph.D. and John J. Kuch, and each of them, his true and lawful attorneys-in-fact, each with full power of substitution, for him in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ BASSIL I. DAHIYAT, PH.D. | Director, President & Chief Executive Officer (Principal Executive Officer) | February 28, 2024 |
| Bassil I. Dahiyat, Ph.D. | ||
| /s/ JOHN J. KUCH | Sr. Vice President & Chief Financial Officer (Principal Financial and Accounting Officer) | February 28, 2024 |
| John J. Kuch | ||
| /s/ A. BRUCE MONTGOMERY, M.D. | Director | February 28, 2024 |
| A. Bruce Montgomery, M.D. | ||
| /s/ KURT GUSTAFSON | Director | February 28, 2024 |
| Kurt Gustafson | ||
| /s/ KEVIN C. GORMAN, PH.D. | Director | February 28, 2024 |
| Kevin C. Gorman, Ph.D. | ||
| /s/ RICHARD RANIERI | Director | February 28, 2024 |
| Richard Ranieri | ||
| /s/ ELLEN G. FEIGAL, M.D. | Director | February 28, 2024 |
| Ellen G. Feigal, M.D. | ||
| /s/ DAGMAR ROSA-BJORKESON | Director | February 28, 2024 |
| Dagmar Rosa-Bjorkeson | ||
| /s/ BARBARA KLENCKE | Director | February 28, 2024 |
| Barbara Klnecke | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.